Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2023 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks if a substantial part of the forward account consists of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, such that the company's own coming volume is a consequence of those parties' trajectories. Looking at the transcript, management discusses various factors: supply, bad debts, skips, consumer behavior, occupancy, rents, development, capital markets. They talk about their own operations, their portfolio, their strategies. They mention "merchant builders" and their behavior, but that's about competition, not about counterparties they supply. They talk about municipalities and courts, but that's not about customers. They talk about their own development projects. They do not describe specific customers, partners, or programs that they supply and whose expansion drives their revenue. The discussion is about market conditions, consumer behavior, supply, and their own management decisions. There is no narrative about a specific counterparty's ramp or build-out that they are embedded in. They mention "merchant builder" concessions, but that's about competitors. They mention "Witten Advisors" as a source of data, not a counterparty. They mention "Freddie and Fannie" as lenders, but not as customers. They talk about their own development pipeline. So the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.